Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow NEUROONE MEDICAL TECHNOLOGIES Corp

Get SEC filing alerts via email and in your feed for NEUROONE MEDICAL TECHNOLOGIES Corp

NMTC

NEUROONE MEDICAL TECHNOLOGIES Corp

About NEUROONE MEDICAL TECHNOLOGIES Corp

NeuroOne Medical Technologies develops advanced thin film electrode technology for diagnosing and treating neurological disorders such as epilepsy, Parkinson’s disease, dystonia, and chronic pain. Its core products include cortical and sEEG electrodes, ablation systems, and stimulation devices, primarily targeting the U.S. market. The company focuses on minimally invasive solutions, integrated diagnostic and therapeutic tools, and leveraging scalable manufacturing to improve clinical outcomes and reduce procedural risks.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from NEUROONE MEDICAL TECHNOLOGIES Corp

1
1
NEUROONE MEDICAL TECHNOLOGIES Corp NeuroOne Reports 72% Revenue Growth in Q2 Fiscal 2026 Despite Net Loss

Via official filing (AI summary) | 23 days ago | 0 comments

2
1
NEUROONE MEDICAL TECHNOLOGIES Corp NeuroOne Reports Decline in Revenue and Increased Net Losses for December 2025 Quarter

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
NEUROONE MEDICAL TECHNOLOGIES Corp NeuroOne Reports 163% Revenue Growth and Strategic Developments in 10-K Filing

Via official filing (AI summary) | 6 months ago | 0 comments

4
1
NEUROONE MEDICAL TECHNOLOGIES Corp NeuroOne Reports $1.7M Product Revenue and Strategic Advancements in Latest 10-Q Filing

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
NEUROONE MEDICAL TECHNOLOGIES Corp NeuroOne Reports Q2 2025 Financial Results with Increased Revenue and Reduced Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
NEUROONE MEDICAL TECHNOLOGIES Corp NeuroOne Reports 234% Revenue Growth and Net Income Turnaround in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments